Mar 6, 2024 · A once-weekly oral regimen can keep HIV suppressed as well as daily pills, according to study results presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).. In a phase II clinical trial, 94% of people who switched to weekly islatravir and lenacapavir pills maintained an undetectable viral load, matching the viral suppression rate of those who stayed on ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

Jul 8, 2020 · Educating clients at a San Francisco sexual health clinic about on-demand pre-exposure prophylaxis (PrEP) increased their desire to use the intermittent HIV prevention method, researchers reported this week at the 23rd International AIDS Conference (AIDS 2020: Virtual).Among the 24% of clients who did so, the rate of new infections and use of post-exposure prophylaxis (PEP) were low.

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

Mar 4, 2024 · Injectable treatment with cabotegravir and rilpivirine proved just as effective in maintaining viral suppression as standard oral antiretroviral treatment in a large trial in Africa, despite less intensive viral load monitoring than previous studies, Professor Nicholas Paton of the London School of Hygiene and Tropical Medicine reported at the Conference on Retroviruses and Opportunistic ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024. If you are a supplier, or another partner you can ...

Mar 18, 2024 · After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

Jul 26, 2021 · Early results from people taking a new antiretroviral medication called lenacapavir are promising. The long-acting drug is still at the research stage, but if the developers are able to pair it effectively with other drugs that also only needs to be taken twice a year, it could revolutionise HIV treatment. Researchers presented the results to the International AIDS Society conference last week ...

Antiretroviral drug chart Generic name Trade name Formulation Standard adult dose Pills/ day Major side effects Food requirements Tenofovir disoproxil

Nov 6, 2018 · After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.